Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.
Hanako Ohashi Ikeda; Yuki Muraoka; Masayuki Hata; Eriko Sumi; Takafumi Ikeda; Takayuki Nakagawa; Hiroyasu Abe; Harue Tada; Satoshi Morita; Akira Kakizuka; Nagahisa Yoshimura; Akitaka Tsujikawa
PloS one, 2020, Peer-reviewed